Literature DB >> 24754458

C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors.

Bo Nilsson1, Osama A Hamad, Håkan Ahlström, Joel Kullberg, Lars Johansson, Lars Lindhagen, Arvo Haenni, Kristina N Ekdahl, Lars Lind.   

Abstract

BACKGROUND: In several reports, C3 and C4 have been linked to diabetes and cardiovascular disease (CVD). Here, we investigate this link and the degree of C3 activation in elderly individuals.
METHODS: In this study, C3 and C4 and the activation fragment C3a-desArg were analysed in 1016 subjects aged 70, in which blood pressure, lipid variables and fasting blood glucose were assessed.
RESULTS: C3 levels were related to all the investigated classical cardiovascular risk factors and the metabolic syndrome (BMI, waist circumference, fat distribution, blood pressure, blood glucose levels, TG) except total cholesterol and LDL cholesterol in a highly significant fashion (Spearman up to 0,5; P < 0·0001). C4 and C3a-desArg were associated in the same fashion but less significantly, while the ratios C4/C3 or C3a-desArg/C3 were not, indicating that the association was not directly related to complement activation. The levels C3 and to a lesser degree C4 and C3a-desArg were associated particularly with CRP, but also with E-selectin and ICAM-1. In addition, C3 and C4 levels were shown to decline significantly in 15 female subjects enrolled in a weight-reduction programme over 4 months.
CONCLUSION: A strong relation between C3, C4 and C3a-desArg levels, adipose tissue and risk factors of CVD was established. The data support that the adipose tissue produces complement components and generates initiators of inflammation, such as C3a and C5a, able to trigger a cyto/chemokine response, in proportion to the amount of adipose tissue. This corroborates the concept that complement contributes to the low-grade inflammation associated with obesity.
© 2014 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  C3; C3a-desArg; C4; cardiovascular disease; metabolic syndrome

Mesh:

Substances:

Year:  2014        PMID: 24754458     DOI: 10.1111/eci.12275

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  28 in total

Review 1.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 2.  Obesity "complements" preeclampsia.

Authors:  Kelsey N Olson; Leanne M Redman; Jenny L Sones
Journal:  Physiol Genomics       Date:  2019-02-04       Impact factor: 3.107

3.  Marked Influence of Adiposity on Laboratory Biomarkers in a Healthy Cohort of Children and Adolescents.

Authors:  Victoria Higgins; Arghavan Omidi; Houman Tahmasebi; Shervin Asgari; Kian Gordanifar; Michelle Nieuwesteeg; Khosrow Adeli
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

4.  High serum complement component C4 as a unique predictor of unfavorable outcomes in diabetic stroke.

Authors:  Ximeng Zhang; Jun Yin; Kai Shao; Le Yang; Wei Liu; Yiqing Wang; Shanshan Diao; Shicun Huang; Qun Xue; Jianqiang Ni; Yi Yang
Journal:  Metab Brain Dis       Date:  2021-09-04       Impact factor: 3.584

5.  Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients.

Authors:  Zheyu Xing; Yaqin Wang; Kunjing Gong; Yuqing Chen
Journal:  BMC Nephrol       Date:  2022-06-29       Impact factor: 2.585

6.  Short- and Long-Term Effects of Weight Loss on the Complement Component C3 After Laparoscopic Gastric Bypass in Obese Patients.

Authors:  Segundo Á Gómez-Abril; Carlos Morillas-Ariño; Jose L Ponce-Marco; Teresa Torres-Sánchez; Fernando Delgado-Gomis; Antonio Hernández-Mijares; Milagros Rocha
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

7.  Complement proteins and arterial calcification in middle aged women: Cross-sectional effect of cardiovascular fat. The SWAN Cardiovascular Fat Ancillary Study.

Authors:  Nayana Nagaraj; Karen A Matthews; Kelly J Shields; Emma Barinas-Mitchell; Matthew J Budoff; Samar R El Khoudary
Journal:  Atherosclerosis       Date:  2015-10-24       Impact factor: 5.162

8.  Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study.

Authors:  Zhenfang Liu; Qin Tang; Jing Wen; Yan Tang; DaMin Huang; Yuzhen Huang; Jinling Xie; Yawen Luo; Min Liang; Chunlei Wu; Zheng Lu; Aihua Tan; Yong Gao; Qiuyan Wang; Yonghua Jiang; Ziting Yao; Xinggu Lin; Haiying Zhang; Zengnan Mo; Xiaobo Yang
Journal:  Sci Rep       Date:  2016-01-04       Impact factor: 4.379

Review 9.  Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?

Authors:  Meena S Madhur; Fernando Elijovich; Matthew R Alexander; Ashley Pitzer; Jeanne Ishimwe; Justin P Van Beusecum; David M Patrick; Charles D Smart; Thomas R Kleyman; Justin Kingery; Robert N Peck; Cheryl L Laffer; Annet Kirabo
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

10.  An Attempt to Evaluate Selected Aspects of "Bone-Fat Axis" Function in Healthy Individuals and Patients With Pancreatic Cancer.

Authors:  Wojciech Blogowski; Katarzyna Dolegowska; Anna Deskur; Barbara Dolegowska; Teresa Starzyńska
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.